CSI Market
Sign In | Register

Aveo Pharmaceuticals Inc (AVEO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AVEO quarterly Cash Flow →
A period-by-period view of cash flow from Aveo Pharmaceuticals Inc to Dec 31 2017 helps clarify how Dec 31 2021's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Operating Activities
Income-53.34
Depreciation & amortization0.07
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.66
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation5.14
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.81
Noncash Interest Expense Income Net-
Increase Decrease In Deferred Rent-
Tangible Asset Impairment Charges-
Non Cash Interest Expense-
Increase Decrease In Accrued Contract Research-
Increase Decrease In Tenant Improvement Allowance Receivable Current-
Litigation Settlement Expense-
Increase Decrease In Settlement Liability-
Increase Decrease In Contract With Customer Liability-1.97
Increase Decrease In Trade Receivables-9.81
Increase Decrease In Operating Lease Right Of Use Asset0.83
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities1.88
Increase (Decrease) in Accounts Payable-0.67
Increase (Decrease) in Other Accrued Liabilities4.04
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.60
Other Working Capital-0.10
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.88
Discontinued operations0.00
Net Cash flow from Operating Activities-57.26
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities11.30
Payments to Acquire Available-for-sale Securities, Debt-28.17
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-16.87
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.88
Long-term debt - borrowings25.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock58.78
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayments Of Loans Payable-
Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Costs-
Proceeds From Issuance Of Common Stock And Warrants To Related Parties-
Proceeds From Issuance Of Loan Payable And Warrants-
Proceeds From Issuance Of Common Stock To Related Party-
Proceeds From Issuance Of Common Stock Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities82.90
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-57.26
Total Cash Flow8.78
4 historic quarters locked

Sign in to unlock the full Aveo Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Aveo Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-22-028635

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License